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The T cell immunoglobulin mucin (TIM) proteins
regulate T cell activation and tolerance. Here we
showed that TIM-4 is expressed on human and
mouse macrophages and dendritic cells, and
both TIM-4 and TIM-1 specifically bound phos-
phatidylserine (PS) on the surface of apoptotic
cells but not any other phospholipid tested.
TIM-4+ peritoneal macrophages, TIM-1+ kidney
cells, and TIM-4- or TIM-1-transfected cells
efficiently phagocytosed apoptotic cells, and
phagocytosis could be blocked by TIM-4 or
TIM-1 monoclonal antibodies. Mutations in the
unique cavity of TIM-4 eliminated PS binding
and phagocytosis. TIM-4 mAbs that blocked
PS binding and phagocytosis mapped to epi-
topes in this binding cavity. These results
show that TIM-4 and TIM-1 are immunologically
restricted members of the group of receptors
whose recognition of PS is critical for the effi-
cient clearance of apoptotic cells and preven-
tion of autoimmunity.
INTRODUCTION
The T cell immunoglobulin mucin (TIM) gene family was
identified as molecules related to higher risk of develop-
ment of asthma and allergic disease in mice (McIntire
et al., 2001). Multiple studies have now confirmed the
association of the TIM gene family with development of
autoimmunity and allergic diseases (reviewed in KuchrooImet al., [2006]). TIM-1 and TIM-3 are preferentially
expressed on distinct mouse T cell subsets, with TIM-1
being on T helper 2 cells (Th2) (Umetsu et al., 2005) and
TIM-3 on Th1 cells (Monney et al., 2002). The TIM gene
family includes three members in human and eight in
mouse. Human TIM-1, TIM-3, and TIM-4 appear to be
the functional orthologs to mouse TIM-1, TIM-3, and
TIM-4 (Kuchroo et al., 2003). Mouse TIM-5 and TIM-8
are inferred from genomic sequences and have not yet
been characterized. All TIM family proteins are type I
cell-surface glycoproteins and share common structural
motifs including an immunoglobulin variable (IgV) domain
with six cysteines, a mucin-like domain, a transmembrane
domain, and a cytoplasmic domain. All TIMs except for
TIM-4 contain a tyrosine-kinase phosphorylation motif in
the cytoplasmic domain. The TIMs differ in the length of
the mucin domain and the number of O-linked glycosyla-
tion sites (Kuchroo et al., 2003).
The crystal structures of murine TIM-1, TIM-2, and
TIM-3 IgV domains have been described (Cao et al.,
2007; Santiago et al., 2007b). TIM-1 and TIM-3 IgV do-
mains display a distinctive cleft formed by the CC0 and
FG loops of the GFC b sheet. This is the face commonly
used by Ig superfamily receptors for ligand binding. This
cavity is conserved within the TIM family, except for
TIM-2. We have found that in TIM-1 and TIM-4, the narrow
cavity built by the CC0 and FG loops is a binding site for
phosphatidylserine (PS). In the accompanying paper,
Santiago et al. (2007a) describe the structure of the co-
crystal of PS and mTIM-4.
The redistribution of PS to the outer leaflet of the plasma
membrane is a key signal for recognition of apoptotic cells
by phagocytes (Fadok et al., 1992; Verhoven et al., 1995).
Rapid removal of apoptotic cells by phagocytes is criticalmunity 27, 927–940, December 2007 ª2007 Elsevier Inc. 927
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TIM-4 Binds Phosphatidylserine on Apoptotic Cellsfor the maintenance of tolerance and prevents inflam-
mation and autoimmune responses against intracellular
antigens released from the dying cells (Savill and Fadok,
2000). Several receptors that participate in the recognition
of PS on the surface of apoptotic cells have been iden-
tified, and deficiencies of these molecules in mouse
models lead to a failure to maintain self-tolerance and
development of autoimmunity (Asano et al., 2004; Cohen
et al., 2002).
Although several reports of the murine TIM family fo-
cused on the interaction between antigen-presenting cells
(APCs) and CD4+ T cells and regulation of Th1 and Th2
balance and tolerance, there are no data on TIM function
in phagocytosis or innate immunity. Here we report that
TIM-4 is expressed on mature macrophages and dendritic
cell (DC) populations in both human and mouse. Our bind-
ing assays and the TIM-4 crystal structure (Santiago et al.,
2007a) showed binding of PS to TIM-4. TIM-4 mAbs that
blocked binding to PS substantially reduced phagocytosis
of apoptotic cells by mouse peritoneal macrophages.
TIM-4- or TIM-1-transfected 3T3 cells and TIM-1-ex-
pressing human kidney epithelial cell lines had increased
apoptotic-cell phagocytosis that could be blocked by
specific mAbs. These results show that TIM-4 and TIM-1
recognize PS and are important for the efficient clearance
of apoptotic cells by antigen presenting cells.
RESULTS
TIM-4 and TIM-1 Bind to a Structure Highly
Expressed on the Surface of Apoptotic Cells
We prepared Ig fusion proteins with the extracellular
domains or the IgV domains of TIM-1, TIM-2, or TIM-4 in
order to identify their functional ligands. TIM-4-Ig and
TIM-1-Ig bound weakly to all long-term-cultured cell lines
tested (data not shown). We noticed that a minor popula-
tion of each cell line had a much higher intensity of staining
with TIM-4-Ig or TIM-1-Ig. On the basis of the side-scatter
and forward-scatter gating of the cells, the brightly stain-
ing cells appeared to be dead cells (Figure 1A); however,
the intensity of staining was much larger than the typical
increase in background staining frequently observed on
dead cells. We prepared Jurkat cells with a moderate
proportion of apoptotic cells by cross-linking CD95 (anti-
Fas, IgM), and we stained the Jurkat cells with TIM-4-Ig
or TIM-1-Ig as well as annexin V-FITC and propidium io-
dide to visualize early and late apoptotic cells. TIM-4-Ig
bound weakly to live Jurkat cells but strongly to a structure
on early and late apoptotic Jurkat cells (Figure 1B).
To further characterize the binding of TIM-1 and TIM-4
to apoptotic cells, we prepared populations with a high
proportion of early apoptotic cells. Treatment of Jurkat
cells with CD95 mAb, followed by centrifugation on Ficoll
to remove late apoptotic cells, gave a population with
more than 90% early apoptotic cells as judged by Annexin
V-FITC and propidium-iodide staining (Figure 1C). We
analyzed the binding of TIM-Ig to these apoptotic cells
or to untreated cells. Binding of TIM-Ig was performed in928 Immunity 27, 927–940, December 2007 ª2007 Elsevier Inthe absence of annexin-V-FITC and propidium iodide to
eliminate any competition or complication by annexin-V
binding to PS. Human (h)TIM-4-Ig, hTIM-1-Ig, mouse
(m)TIM-4(IgV)-Ig, and mTIM-1(IgV)-Ig bound slightly to
live Jurkat cells but strongly to apoptotic Jurkat cells
(Figure 1D).
Red blood cells (RBCs) can be induced to undergo an
apoptotic-like process, termed eryptosis, by incubation
with ionomycin and phorbol ester. Eryptotic RBCs expose
PS on the RBC surface (Figure 1C). Human TIM-4-Ig,
hTIM-1-Ig, mTIM-4(IgV)-Ig, and mTIM-1(IgV)-Ig did not
bind detectably to fresh RBCs but bound strongly to eryp-
totic RBCs (Figure 1D and data not shown). In contrast,
mTIM-2(IgV)-Ig or control Ig did not bind to any cell tested.
Similar binding results with these TIM-Ig were seen with
several mouse (300.19, FL5.12) and human (Jurkat,
U937) cell lines after induction of apoptosis by various
methods (cytokine deprivation, etoposide, Fas-mediated)
(data not shown). Binding was not species restricted. In
contrast, freshly isolated human T cells did not bind any
of the TIM-Ig (data not shown).
By preincubating TIM-Ig with TIM mAbs known to rec-
ognize the IgV domain, we tested the capacity of TIM
mAbs to block the interaction with apoptotic cells. The
interaction of hTIM-4-Ig with apoptotic cells was blocked
by hTIM-4 mAb 9F4 but not by mAb 4E11 (Figure 1E). The
interaction of hTIM-1-Ig was blocked by hTIM-1 mAb 3D1
and moderately blocked by hTIM-1 mAb 1D12 (Figure 1F).
Thus, blockade by mAbs that recognize the IgV domain as
well as binding by TIM-4 and TIM-1 fusion proteins con-
taining the IgV but not the mucin domain indicates that
the critical recognition structure for apoptotic cells is con-
tained in the IgV domain alone.
TIM-4 and TIM-1 Bind to PS
Exposure of PS on the outer-membrane leaflet is a major
difference between live and apoptotic cells, so we tested
whether TIM-1 and TIM-4 recognize PS by using
PS-coated plates in a solid-phase enzyme-linked immu-
nosorbent assay (ELISA). Murine TIM-1(IgV)-Ig and
mTIM-4(IgV)-Ig bound to PS-coated plates in a concentra-
tion-dependent manner; however, mTIM-2(IgV)-Ig did not
bind (Figure 2A). Human TIM-1-Ig, hTIM-4-Ig, mTIM-
1(IgV)-Ig, and mTIM-4(IgV)-Ig bound to plates coated
with PS, but not to plates coated with phosphatidylinositol
(PI), phosphatidylcholine (PC), or phosphatidylethanol-
amine (PE) (Figure 2B). Murine TIM-2(IgV)-Ig did not bind
to any of these phospholipids, even at high concentrations
of TIM-2-Ig.
To determine the binding of TIM proteins to other phos-
pholipids, we employed a protein-lipid overlay assay using
nitrocellulose membranes on which various phospholipids
had been spotted (PIP strip). Figure 2C shows that mTIM-
1 and mTIM-4 specifically bound to PS but not to the other
phospholipids, except for a slight binding to cardiolipin.
These findings indicate that human and mouse TIM-1
and TIM-4 specifically recognize PS via the IgV domain
of the TIM molecule.c.
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TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 1. TIM-4 and TIM-1, but Not TIM-2, Fusion Proteins Bind to Apoptotic Cells
(A) An overgrown culture of 300.19 cells was stained with hTIM-4-Ig (open curves) or control mIgG2a (filled gray curves). Cells gated on live or dead
cells by forward and side scatter were analyzed by flow cytometry. Data shown are representative of more than five experiments.
(B) Jurkat cells treated with Fas mAb were stained with hTIM-4-Ig (open curves) or control mIgG2a (filled gray curves) followed by allophycocyanin-
conjugated goat anti-mouse IgG2a and annexin-V FITC and propidium iodide. Cells gated on live, early, and late apoptotic cells as indicated were
analyzed by flow cytometry. Data shown are representative of more than five experiments.
(C) Jurkat cells untreated (left panel) or made apoptotic with Fas mAb (right panel) were ficolled to remove late apoptotic cells and stained with
annexin-V FITC and propidium iodide. Fresh untreated RBCs (left panel) or RBCs made eryptotic by treatment with ionomycin and CaCl2 (right panel)
were stained with annexin-V FITC and propidium iodide. Data shown are representative of three experiments.
(D) Untreated or apoptotic Jurkat cells and fresh or eryptotic RBCs made as in (C) were stained with 1.2 mg/ml of hTIM-4-Ig, or with 5 mg/ml of
mTIM-1(IgV)-Ig, mTIM-2(IgV)-Ig, or mTIM-4(IgV)-Ig (open curves), or with isotype control mouse IgG2a (filled gray curves). Ig FPs were detected
with PE-conjugated anti-mouse IgG2a. Live or apoptotic Jurkat cells were stained with hTIM-1-Ig or isotype control and detected with PE-conjugated
anti-human IgG. Data shown are representative of three or more experiments.
(E) Human TIM-4-Ig was preincubated with 10 mg/ml of TIM-4 mAbs 9F4 (red line), 4E11 (blue line), or isotype control mouse IgG1 (black line) before
the staining of apoptotic Jurkat cells. Filled gray indicates the staining with isotype control mouse IgG2a. Data are representative of three experi-
ments.
(F) Human TIM-1-Ig was preincubated with 10 mg/ml of TIM-1 mAbs 3D1 (red line), 1D12 (blue line), or isotype control (black line) before the staining of
apoptotic Jurkat cells. Filled gray indicates staining with control hIgG FP. Data shown are representative of three experiments.Human TIM-1 and TIM-4 Facilitate Engulfment
of Apoptotic Cells by Transfected NIH 3T3 Cells
Recognition of cell-surface PS is a critical signal for clear-
ance of dead cells by phagocytes (Fadok et al., 1992;
Verhoven et al., 1995). To study the function of TIM-1
and TIM-4 in phagocytosis of apoptotic cells, we trans-
fected hTIM-1 or hTIM-4 into NIH 3T3 cells. Stable
hTIM-1 or hTIM-4-3T3 expressed moderate amounts ofImeach molecule on their cell surfaces (Figure S1 available
online). Flow cytometry was used to measure uptake of
CMTMR-labeled live or apoptotic U937 cells or PKH67-
labeled fresh or eryptotic RBCs by transfected 3T3 cells
(Figures 3A–3C). Live U937 cells or fresh RBCs did not
bind and were not phagocytosed by TIM-1, TIM-4, or
untransfected 3T3 cells. In contrast, apoptotic U937 (Fig-
ures 3A and 3B) or eryptotic RBCs (Figure 3C) were rapidlymunity 27, 927–940, December 2007 ª2007 Elsevier Inc. 929
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TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 2. TIM-1 and TIM-4, but Not TIM-2, Bind to Phosphatidylserine and Not Other Phospholipids
(A) ELISA plates coated with PS were incubated with mTIM-4(IgV)-Ig, mTIM-1(IgV)-Ig, mTIM-2 (IgV)-Ig, anti-PS mAb, or isotype control mouse
IgG2a as indicated. Fusion proteins not bound to the plates were removed by washing, and bound protein was quantified by ELISA. Data are shown
as mean ± standard deviation (SD) of duplicate wells and are representative of three independent experiments.
(B) ELISA plates coated with PS, PE, PC, or PI or without phospholipid were incubated with the indicated concentrations of hTIM-4-Ig, hTIM-1-Ig,
mTIM-4(IgV)-Ig, mTIM-1(IgV)-Ig, or mTIM-2(IgV)-Ig. TIM-Ig bound to wells was quantified by ELISA. Data are shown as mean ± SD of duplicate wells
and are representative of three independent experiments.
(C) mTIM-4 and mTIM-1 bind strongly to phosphatidylserine on PIP strips. Two micrograms per milliliter of mTIM-4(IgV)-Ig (left) or mTIM-1(IgV)-Ig
(right) were incubated with strips spotted with the indicated phospholipids, washed, and developed with anti-mouse IgG2a-HRP. Data shown are
representative of two experiments.and efficiently phagocytosed by hTIM-1- or hTIM-4-trans-
fected 3T3. Apoptotic U937 or eryptotic RBCs were slowly
and inefficiently phagocytosed by untransfected 3T3.
Electron microscopy and three-dimensional imaging by
confocal microscopy showed that uptake of apoptotic
U937 by TIM-1- or TIM-4-transfected cells was truly
phagocytosis because the apoptotic cells were com-
pletely engulfed and internalized (Figures 3D–3I and data
not shown). Labeling of apoptotic U937 with the pH-sen-
sitive dye, CypHer5E (Beletskii et al., 2005), showed that
the phagocytosed U937 was compartmentalized into an
acidic compartment such as a phagosome (Figure 3E
and Figure S5). Using eryptotic RBCs, we saw a similar
enhancement of phagocytosis in TIM-1- or TIM-4-trans-
fected 3T3 cells. (Figure S2).
To test whether PS is the molecule recognized by TIM-1
and TIM-4 in phagocytosis of apoptotic cells, we prepared
phospholipid liposomes containing various phospholipids
and tested their capacity to inhibit phagocytosis by TIM
transfectants. Liposomes containing equal amounts of
PS and PC (PS + PC) reduced phagocytosis by both930 Immunity 27, 927–940, December 2007 ª2007 Elsevier IncTIM-1 and TIM-4 transfectants in a concentration-depen-
dent fashion with complete inhibition at 10 mM of total
phospholipids (Figure 3J). Inhibition of phagocytosis was
not observed with liposomes containing another anionic
lipid, PI, nor with PC or PE (Figures 3J and 3K). These
observations show that recognition of PS on the plasma
membrane by hTIM-4 and hTIM-1 depends not only on
the anionic charge of PS but also on highly specific recog-
nition of PS structural features.
TIM-4 Is Expressed by Macrophages
and Dendritic Cells
TIM-4 mRNA expression has been reported in mouse
spleen and lymph node (Meyers et al., 2005; Shakhov
et al., 2004), but which cells display surface TIM-4 is
unclear. We found that resident mouse peritoneal cells ex-
press higher amounts of TIM-4 mRNA than splenocytes
(Figure 4A). To identify the cell-surface expression of
TIM-4, we used two-color staining with F4/80 to identify
peritoneal macrophages (PMf) and either of two mTIM-4
mAbs. PMf expressed high amounts of TIM-4 but no.
Immunity
TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 3. hTIM-1- or hTIM-4-Transfected NIH 3T3 Cells Phagocytose Apoptotic U937 Cells or Eryptotic RBCs but Not Live Cells
(A–D) CMTMR-labeled live or apoptotic U937 or PKH67-labeled live or eryptotic (Eryp) RBCs were cocultured with 3T3, hTIM-1 3T3, or hTIM-4 3T3 for
45 or 90 min, nonadherent cells were washed off, and adherent cells were detached and analyzed by flow cytometry or electron microscopy for
phagocytosis of labeled cells. (A) FACS profiles for phagocytosis of live or apoptotic U937 by 3T3 (black line), hTIM-1 3T3 (blue line), or hTIM-4
3T3 (red line) after 90 min coincubation. Data are representative of three experiments. (B and C) Phagocytosis assays with (B) U937 cells or (C)
RBCs were done in duplicate, and mean values are plotted with SD and are representative of three experiments. (D) Electron micrograph of apoptotic
U937 phagocytosed by hTIM-4 3T3. Original magnification was 50003. Data are representative of two experiments.
(E) Photomicrograph of CypHer5E-labeled apoptotic U937 compartmentalized to an acidic compartment of hTIM-4 3T3. Data are representative of
two experiments.
(F–I) 3T3 cells (F) or hTIM-1 3T3 (G–I) were labeled with CMFDA (green). U937 were labeled with CMTMR (red) and made apoptotic by 5 hr treatment
with etoposide. 3T3 cells and apoptotic U937 cells were cocultured for 2 hr, washed, and visualized by confocal microscopy as described in the
Experimental Procedures. An enlarged image of the boxed region in (G) is shown in (H), and a side image is shown in (I). Data are representative
of two experiments.
(J) Phagocytosis of eryptotic RBCs by hTIM-1 3T3 or hTIM-4 3T3 was inhibited by liposomes containing a 50:50 mix of PS and PC but not by PC alone.
hTIM-1 or TIM-4 3T3 were preincubated with liposomes for 15 min and cocultured with PKH67-labeled eryptotic RBCs for 45 min. After the washing
out of nonattached cells, 3T3 cells were detached and analyzed by flow cytometry for phagocytosis of eryptotic RBCs. Phagocytosis of eryptotic
RBCs in the absence of liposomes represents 100%. Data are shown as mean ± SD of duplicate wells and are representative of three independent
experiments.
(K) Phagocytosis of eryptotic RBCs by hTIM-1 or hTIM-4 3T3 was inhibited by liposomes containing PS but not PC, PE, or PI. hTIM-1 or TIM-4 3T3
cells were preincubated with 1 or 10 mM of liposomes containing the indicated phospholipids. Assays were done as described in (J). Data are shown
as mean ± SD of duplicate wells and are representative of three independent experiments.detectable TIM-1 (Figure 4B). TIM-4 staining was present
in moderate abundance on both CD8a+ and CD8a sub-
sets of CD11c+ DCs, consistent with the initial identifica-
tion of TIM-4 mRNA expression in CD11c+ cells (Meyers
et al., 2005), but was not detectable on plasmacytoid
DCs (Figure 4C) or GM-CSF-stimulated bone-marrow-de-
rived DCs (data not shown). TIM-4 was not detected on
unstimulated CD19+ B cells (Figure 4C) or B cells stimu-
lated with lipopolysaccharide (LPS) or CD40 mAb (dataInot shown). TIM-4 was not detected on resting or acti-
vated T cells, but TIM-1 was expressed on activated T
cells (Umetsu et al., [2005] and data not shown).
Human lymphoid tissues such as tonsil, thymus, and
spleen, as well as testis, expressed TIM-4 mRNA by
qRT-PCR (Figure 4D). Kidney, liver, and lung expressed
low amounts of TIM-4 mRNA, and peripheral blood
mononuclear cells (PBMCs) expressed very low amounts.
To determine whether human Mf express TIM-4, wemmunity 27, 927–940, December 2007 ª2007 Elsevier Inc. 931
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TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 4. TIM-4 Is Expressed in Macrophages and Dendritic Cells
(A) qRT-PCR analysis of TIM-4 mRNA expression in the indicated mouse tissues and a mouse pre-B cell line (300.19). Data are representative of three
experiments.
(B) Cell-surface expression of mTIM-4. Mouse resident peritoneal cells were stained with F4/80-allophycocyanin mAb and anti-mTIM-4-PE mAb
(21H12 or QT3) or anti-mTIM-1-PE and analyzed by flow cytometry. The percent of cells in each quadrant is indicated. Data are representative of
four experiments.
(C) Mouse splenic cells were stained with the indicated lineage-specific markers and anti-mTIM-4-PE. Filled gray curves represent isotype-control
staining, and open curves represent staining of lineage-gated cells with mTIM-4 mAb. Results are representative of three experiments.
(D) qRT-PCR analysis of TIM-4 mRNA expression in the indicated human tissues. Data are representative of two experiments.
(E) qRT-PCR analysis of TIM-4 mRNA expression in human splenic macrophages. Splenic macrophages were enriched with CD14 MACS beads or by
adhesion as described in Experimental Procedures. Data are representative of three experiments.
(F–G) Immunohistochemistry showing TIM-4 expression in (F) human tonsil and (G) spleen. Sections of paraffin-embedded tissue were stained with
polyclonal hTIM-4 antibody. Isotype control was normal goat IgG. All micrographs were obtained with the 203 objective, except for the inserted frame
in the upper-left panel in (F) (403). Staining is representative of five or more experiments except for absorbed antisera, which was done once.932 Immunity 27, 927–940, December 2007 ª2007 Elsevier Inc.
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TIM-4 Binds Phosphatidylserine on Apoptotic Cellsprepared human splenic Mf either by positive selection
with CD14 MACS microbeads or by adherence to tis-
sue-culture plastic (see Experimental Procedures).
Splenic adherent and CD14+ cells expressed high
amounts of TIM-4 mRNA, whereas nonadherent and
CD14 cells expressed little TIM-4 mRNA (Figure 4E). Hu-
man splenic CD14highCD11clowCD11b+ cells, consisting
of Mf and immature DCs, expressed high amounts of
TIM-4 mRNA, but CD14CD11chighCD11b, consisting
of mature DCs in human spleen, expressed little TIM-4
mRNA (data not shown). Human peripheral blood mono-
cytes did not express detectable amounts of cell-surface
TIM-4 (data not shown).
To further characterize the expression of TIM-4 in
human tissue, we performed immunohistochemistry of
tonsil (Figure 4F) and spleen (Figure 4G) with goat anti-
hTIM-4 polyclonal antibody. Tingible-body Mf located in
germinal centers of tonsil or white pulp of spleen showed
expression for TIM-4. Tingible bodies are the remnants of
cells phagocytosed by macrophages, and tingible-body
macrophages are the cells that engulf apoptotic cells in
lymphoid tissue (Smith et al., 1991). There was no staining
with control goat IgG (Figures 4F and 4G). The specificity
of TIM-4 staining was further confirmed by showing that
absorption of the TIM-4 antibody on TIM-4 transfected
300.19 cells removed the reactivity, whereas absorption
on untransfected 300.19 cells did not (Figure 4F). These
results show that macrophages in human and mouse
express TIM-4.
Phagocytosis of Apoptotic Thymocytes
by Mouse Peritoneal Macrophages
Was Reduced by TIM-4 mAb
To assess the involvement of TIM-4 in phagocytosis of
apoptotic cells, we preincubated PMf with increasing
amounts of 21H12 mAb or isotype control. PMf were
then cocultured with PKH67-labeled apoptotic thymo-
cytes for 30 min, and phagocytosis was measured by
flow cytometry (Figures 5A and 5B). Approximately 44%
of the PMf phagocytosed apoptotic thymocytes, and
this percentage was not affected by isotype control anti-
body. In contrast, 2 or 10 mg/ml of mTIM-4 mAb 21H12 re-
duced the percentage of PMf that engulfed apoptotic
cells to 13.6%. These results suggested that TIM-4 is
one of the receptors used by mouse PMf to recognize
and phagocytose apoptotic cells.
The Human Kidney Cell Line 769P Phagocytoses
Apoptotic Cells through Human TIM-1
Some human kidney cell lines show natural surface
expression of TIM-1. We confirmed that 769P cells (Vila
et al., 2004), derived from a renal clear-cell carcinoma, ex-
press TIM-1 on their cell surface by using hTIM-1 antibody
3D1 (Figure 6A). In contrast, 769P cells did not express
TIM-4. To test whether 769P cells phagocytose apoptotic
cells via TIM-1, we cultured 769P cells with apoptotic
U937 cells or eryptotic RBCs and measured phagocyto-
sis. During a 2 hr incubation, 769P cells phagocytosed
apoptotic U937 (41.9%), but not live U937 (0.35%) (dataImnot shown). The internalization of apoptotic cells was con-
firmed by three-dimensional imaging by confocal micros-
copy (Figure 6B). 769P cells also phagocytosed eryptotic
RBCs much more efficiently than fresh RBCs (Figure 6C).
Using the TIM-1 mAbs 3D1 and 1D12, which blocked the
binding of TIM-1-Ig to apoptotic Jurkat cells (Figure 1F),
we found that binding and phagocytosis of apoptotic cells
was blocked by these TIM-1 antibodies in a concentra-
tion-dependent manner (Figure 6D and Figure S3). These
studies show that 769P cells can recognize and phagocy-
tose apoptotic cells through TIM-1 on their cell surface.
CC0FG Ligand Binding Cavity Is Critical
for Phagocytosis of Apoptotic Cells
The crystal structure of mTIM-4 showed that PS binds in
the cavity built up by the CC0 and FG loops and suggests
that this cavity is important for biological function
(Santiago et al., 2007a). To test the function of this site in
phagocytosis of apoptotic cells, we prepared alanine
substitutions of each of the four amino acids comprising
this cavity at the FG loop (W119-D122). Hydrophobic
W119 and F120 are located at the top of the FG loop.
N121 and D122 are at the bottom of this cavity and trap
positively charged ions. Each mutant was transfected
into NIH 3T3 cells, and transfectants were identified with
polyclonal goat anti-hTIM-4 antibody (Figure 7A). Alanine
substitutions in W119-D122 did not affect binding by the
4E11 hTIM-4 mAb. In contrast, the W119A, F120A, or
N121A—but not D122A—substitution destroyed the epi-
tope that is on TIM-4 and recognized by the 9F4 mAb.
These results show that 9F4 mAb recognizes the FG
Figure 5. TIM-4mAbBlockedPhagocytosis of Apoptotic Thy-
mocytes by Mouse Peritoneal Macrophages
(A) Mouse PMf were preincubated with 10 mg/ml isotype control or
21H12 mTIM4 mAb for 5 min followed by PKH67-labeled apoptotic
thymocytes for 30 min. Nonadherent cells were removed by washing,
and PMfwere detached and stained with anti-CD11b-PE. The phago-
cytosis of PKH67-labeled apoptotic thymocytes by CD11b+ cells was
analyzed by flow cytometry, and the percent of cells in each quadrant
is indicated. Data are representative of four experiments.
(B) Phagocytosis assays were performed as in (A) with the indicated
concentrations of 21H12 or isotype control. Data are shown as mean
± SD of duplicate wells and are representative of three independent
experiments.munity 27, 927–940, December 2007 ª2007 Elsevier Inc. 933
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TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 6. Human Kidney Cell Line 769P Expressed hTIM-1 and Phagocytosed Apoptotic U937 Cells and Eryptotic RBCs through
hTIM-1
(A) 769P cells were stained with PE-conjugated hTIM-1 mAb (3D1) or hTIM-4 mAb (9F4) (open curves) or isotype control (filled gray curves) and
analyzed by flow cytometry. Data are representative of three experiments.
(B) CMFDA-labeled 769P cells (green) and CMTMR-labeled apoptotic U937 cells (red) were cocultured for 2 hr, nonadherent cells were washed off,
and remaining cells were fixed and visualized by confocal microscopy. The right panel shows a side view of the left panel. Data are representative of
two experiments.
(C) PKH67-labeled fresh and eryptotic RBCs were cocultured with 769P cells for 45 min or 90 min, nonadherent cells were washed off, and remaining
cells were detached and analyzed for PKH67-positive RBCs in 769P cells by flow cytometry. The FACS profiles for PKH67-positive RBCs in 769P cells
(open curves) and 769P cells without RBCs (filled gray curves) are shown in the upper panel and presented graphically in the lower panel. Assays were
done in duplicate, and mean values are plotted with SD. Data are representative of four experiments.
(D) Phagocytosis of eryptotic RBCs was blocked by hTIM-1 mAb. 769P cells were preincubated with 3D1, 1D12, or isotype control for 30 min and
cocultured with PKH67-labeled eryptotic RBCs for 90 min; nonadherent cells were washed off, and remaining cells were detached and analyzed
for PKH67-positive RBCs in 769P by flow cytometry. FACS profiles for PKH67-positive RBCs in 769P incubated with 2 mg/ml 3D1 (red line), 1D12
(blue line), or isotype control (black line) are shown in the upper panel and presented graphically in the lower panel. Filled gray curve represents
769P cells in the absence of RBCs. Data are shown as mean ± SD of duplicate wells and are representative of three independent experiments.loop of hTIM-4, whereas the 4E11 mAb reacts outside this
area. This epitope mapping is consistent with the capacity
of 9F4, but not 4E11, to reduce phagocytosis of eryptotic
RBCs by hTIM-4 transfected 3T3 cells (Figure 7B).
The phagocytic capacity of untransfected, wild-type,
and mutant TIM-4-transfected 3T3 cells was compared
(Figures 7C and 7D and Figure S4). Wild-type hTIM-
4-transfected 3T3 efficiently phagocytosed eryptotic
RBCs with 70% of the cells phagocytosing an RBC after
90 min, whereas untransfected 3T3 phagocytosed
eryptotic RBCs poorly, with only 17% of the cells phago-
cytosing an RBC after 90 min. All 3T3 lines transfected
with mutant TIM-4 (W119A, F120A, N121A, and D122A)
had reduced phagocytic activity equivalent to that of
untransfected 3T3. These results show that the PS binding
cavity composed of W119 to D122 is necessary for the
recognition and phagocytosis of apoptotic cells by TIM-4.
DISCUSSION
In this study we have shown that TIM-4 and TIM-1 recog-
nize PS on the surface of apoptotic cells. TIM-4 mAb
reduced phagocytosis of apoptotic cells by PMf. Trans-
fection of TIM-4 or TIM-1 into NIH 3T3 cells greatly aug-
mented their capacity to phagocytose apoptotic cells.
This phagocytic activity was completely blocked by lipo-
somes containing PS but not PC, PI, or PE. We identified934 Immunity 27, 927–940, December 2007 ª2007 Elsevier InmAbs that were against mouse and human TIM-4 and
TIM-1 and would block binding to PS and phagocytosis.
All the blocking mAbs mapped to the IgV domain on which
the PS binding cavity is located. Consistent with a role in
recognition of apoptotic cells, TIM-4 is highly expressed
on phagocytic cells such as peritoneal macrophages, tin-
gible-body macrophages, and dendritic cells.
PS comprises about 7% of the phospholipid of a cell but
is compartmentalized to the inner leaflet of the cell mem-
brane. The redistribution of PS to the external surface of
the plasma membrane is a key element of apoptotic cell
recognition and is a molecular cue that dying cells should
be phagocytosed (Fadok et al., 1992; Verhoven et al.,
1995). Healthy Jurkat cells expose about 0.9 attomol
(600,000 molecules) of PS per cell, which rises to about
240 attomol/cell late in apoptosis (Borisenko et al.,
2003). Macrophages inefficiently phagocytose Jurkat
cells expressing this low, healthy level of PS, and phago-
cytosis increases only after a threshold surface level of
about 5 attomol/cell is passed and plateaus above
25 attomol/cell (Borisenko et al., 2003). All healthy long-
term cell lines showed a low amount of binding of TIM-1
and TIM-4, consistent with their low but detectable expo-
sure of cell-surface PS as measured by PS mAb or Annex-
inV-FITC (data not shown). In contrast, TIM-1 and TIM-4
did not bind to T cells from freshly isolated blood (data
not shown). This is consistent with the fact that in vivo,c.
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TIM-4 Binds Phosphatidylserine on Apoptotic CellsFigure 7. Mutants in the hTIM-4 CC0FG Cavity Do Not Phagocytose Apoptotic Cells
(A) Binding of hTIM-4 antibodies to mutant hTIM-4-transfected 3T3 cell lines. Wild-type hTIM-4 and mutant hTIM-4 (W119A, F120A, N121A, and
D122A) were transfected into NIH 3T3 cells. Wild-type or mutant hTIM-4 3T3 were stained with 9F4, 4E11, or polyclonal hTIM-4 antibody and analyzed
by flow cytometry. Open curves represent staining with hTIM-4 antibody, and the filled gray curves represent staining with isotype control antibody.
Numbers in the panels are mean fluorescence intensity of the TIM-4-stained cells. Data are representative of two experiments.
(B) 9F4 but not 4E11 blocked phagocytosis of eryptotic RBCs by hTIM-4 3T3. hTIM-4 3T3 were preincubated with 9F4, 4E11, or isotype control mouse
IgG1 for 30 min and cocultured with PKH67-labeled eryptotic RBCs; nonadherent cells washed off, and remaining cells were detached and analyzed
for PKH67-positive RBCs in hTIM-4 3T3 by flow cytometry. Assays were done in duplicate, and mean values are plotted with SD. Data are represen-
tative of three experiments.
(C and D) Phagocytosis of PKH67-labeled eryptotic RBCs by mutant TIM-4 3T3. The indicated TIM-4 3T3 transfectants were cocultured with PKH67-
labeled eryptotic RBCs, nonadherent cells were washed off, and remaining cells were detached and analyzed for PKH67-positive RBCs in hTIM-4 3T3
by flow cytometry. FACS profiles of 90 min culture are shown in (C). Filled gray curves represent untransfected 3T3 with eryptotic RBCs, and open
curves represent the indicated TIM-4 transfectant with eryptotic RBCs. Results at 45 and 90 min are presented graphically in (D). Data are shown as
mean ± SD of duplicate wells and are representative of three independent experiments.cells exposing PS are rapidly phagocytosed, whereas
in vitro, cell lines are not monitored as stringently because
professional phagocytic cells are not present.
Several receptor combinations that participate in the
recognition of PS on the surface of apoptotic cells have
been identified, including Milk fat globule EGF-factor 8
(MFG-E8) (Hanayama et al., 2002) and Growth arrest-Imspecific gene 6 (GAS6) (Scott et al., 2001). These are
two component systems composed of a soluble PS ‘‘teth-
ering’’ molecule such as MFG-E8 or GAS6 and a mem-
brane-bound ‘‘tickle’’ molecule, such as aVb3 or aVb5
integrin or Mer, responsible for recognition of the ‘‘tether’’
and internalization and signaling. A PS receptor on the sur-
face of macrophages has been described; however, themunity 27, 927–940, December 2007 ª2007 Elsevier Inc. 935
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2000) has been discredited (Williamson and Schlegel,
2004). TIM-4 is a likely candidate for this macrophage
PS receptor, with the IgV domain forming the ‘‘tether’’
that binds PS and the extended mucin domain providing
a ‘‘tickle’’ to the TIM transmembrane and cytoplasmic
domains. Although the involvement of TIM-4 in phagocy-
tosis seems clear, the cytoplasmic domain of TIM-4
does not contain any tyrosine signaling motifs, and the
signaling pathway requires further study. Recognition of
PS by TIM-4 and TIM-1 was highly specific, whereas other
PS-binding molecules such as MFG-E8 (Hanayama et al.,
2002), GAS6 (Nagata et al., 1996; Nakano et al., 1997),
b2-glycoprotein (Balasubramanian et al., 1997), and lec-
tin-like oxidized low-density lipoprotein receptor 1 (Oka
et al., 1998) bind not only PS but also other anionic phos-
pholipids.
Phagocytosis of apoptotic cells is evolutionarily ancient,
and PS-recognition molecules such as MFG-E8 and GAS6
are broadly expressed in tissues. In contrast, expression
of TIM-4 is highly restricted to professional antigen-
presenting cells (APCs) and testis, suggesting an immuno-
logically restricted function in recognition of apoptotic
cells. Given the redundant systems that recognize apo-
ptotic cells, the strong effects of TIM-1 or TIM-4 mabs or
fusion proteins are impressive.
The cocrystal structure of PS bound to TIM-4 shows
a direct interaction not mediated by intervening molecules
(Santiago et al., 2007a). The specific binding of PS to
TIM-4 is due to the unique structure of TIM IgV domains.
The four noncanonical cysteines found in all TIM family
members form disulfide bonds that reverse and fix the
folded conformation of the long CC0 loop onto the GFC
b sheet (Cao et al., 2007; Santiago et al., 2007b). Instead
of the relatively flat binding surface found in most Ig super-
family ligand-recognition surfaces, the CC0FG loops form
a narrow cavity with dimensions of approximately 7 3
9 3 11 A˚. The outer lips of the cavity are composed of
hydrophobic amino acids positioned to interact with
the hydrophobic fatty-acid region of PS. The bottom of
the cavity is composed of charged amino acids that
capture a metal ion and coordinate with the charged
head of the PS.
Mutation of any of the amino acids (119–122, WFND)
that line this binding cavity eliminates binding to PS and
phagocytosis. The 9F4 mAb that blocks TIM-4 binding
to PS maps to this epitope. The structures of mouse and
human TIM-1 and TIM-4 are very highly conserved in
this region, whereas TIM-2 is completely different (--AF,
where - indicates a gap in the aligned sequences). This
probably explains the similar recognition of PS by TIM-4
and TIM-1 and the different ligand binding of TIM-2.
Clearly, TIM-2 is an outlier in the TIM family, and binding
to proteins including Semaphorin4A and h-Ferritin has
been reported. TIM-1 and TIM-4 have been reported to
be ligands for each other on the basis of the binding of
TIM-1-Ig to TIM-4 transfectants and vice versa (Meyers
et al., 2005); however, Biacore studies with highly purified
protein showed the TIM-1:TIM-4 interaction was of very936 Immunity 27, 927–940, December 2007 ª2007 Elsevier Inlow affinity (Sizing et al., 2007). In our assays of TIM-
mediated phagocytosis, the apoptotic cell did not express
TIM-1 or TIM-4, thereby excluding a TIM:TIM interaction.
Some of the low-level, universal binding of TIM proteins
observed by us and others (Cao et al., 2007; Wilker
et al., 2007) might reflect the health of the cell and its level
of exposure of PS. In addition, some apparent TIM-1:
TIM-4 interactions could reflect a ‘‘bridge’’ with two TIM
proteins binding to a membrane fragment via exposed PS.
TIM-1 was also cloned as kidney injury molecule 1
(KIM-1) and is expressed minimally by healthy kidney
but in postischemic kidney is highly unregulated on the
luminal side of dedifferentiated tubule epithelial cells (Ichi-
mura et al., 1998). Although the function of TIM-1 in recov-
ery from ischemic-kidney injury is not yet clear, our results
show that TIM-1 on a renal cell carcinoma line mediates
phagocytosis of apoptotic cells and suggests that one of
the functions of TIM-1 on dedifferentiated tubular epithe-
lial cells might be recognition of dead cells after ische-
mic-kidney injury and clearance of dead cells to reconsti-
tute the tissue. In addition, TIM-1 ectodomain has been
shown to be shed from the injured kidney (Han et al.,
2002) and may regulate the recognition of apoptotic cells
either by opsonization or by blockade. Although TIM-1 can
mediate phagocytosis in a large kidney cell, it may func-
tion on a small T cell more to receive signals via small exo-
somes or to sense the activation status of the T cell and
the health of the APC and surrounding tissue.
In vivo administration of either TIM-4-Ig or TIM-1-Ig
resulted in hyperproliferation of T cells and enhancement
of T cell cytokine production (Meyers et al., 2005). The
administration of TIM-1 agonistic mAb enhanced T cell
activation and proliferation, induced increased airway in-
flammation, and blocked development of respiratory tol-
erance (Umetsu et al., 2005). On T cells, TIM-1 associates
with the T cell receptor, and crosslinking with TIM-1 mAb
leads to engagement of tyrosine signaling motifs in the
cytoplasmic domain of TIM-1 and higher production of
Th2 cytokines (Binne et al., 2007; de Souza et al., 2005).
A common perplexing feature of in vivo treatment with
TIM mAbs or fusion proteins is the finding that at a time
when T cells should have returned to quiescence, T cells
taken from the treated animal and assayed in vitro are still
proliferating and producing cytokines. During a primary T
cell response in vivo, T cells expand exponentially and
then 90% or more die by apoptosis and are phagocy-
tosed. T cell activation leads to a rise of exposed PS on
the surface of the T cell, and this PS is associated with lipid
rafts and the immunological synapse (Fischer et al., 2006).
Although some in vitro-activated T cells express high
levels of PS and progress to activation-induced cell death,
the majority express an intermediate level of PS, survive,
and restore PS exposure to normal levels. TIM-mediated
recognition of PS on activated T cells may have a role as
T cells pass through this ‘‘near-death’’ experience. The
extended T cell response caused by TIM blockade may
be due to prevention of phagocytosis of activated T cells
exposing PS. Rapid removal of apoptotic cells by phago-
cytes is critical for the maintenance of tolerance andc.
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against intracellular antigens released from the dying cells
(Savill and Fadok, 2000) (Wu et al., 2006). Disruption of this
process may explain the genetic association of the TIM
gene family with auotoimmunity and asthma.
EXPERIMENTAL PROCEDURES
Case Material
Case materials were obtained from the Brigham & Women’s Hospital
and Dana-Farber Cancer Institute (Boston, MA) after institutional re-
view board (IRB) approval and in accordance with institutional policies.
Mice
All mouse experiments were approved by the Animal Care and Use
Committee of the Dana-Farber Cancer Institute or Children’s Hospital
Boston. C57BL/6 and BALB/cByJ mice were purchased from Jackson
Laboratories. For the collection of resident peritoneal cells, mice were
sacrificed and the peritoneal cavities were infused with 3 ml of ice-cold
PBS + 0.3% BSA + 0.03% EDTA, and cells were recovered and
washed three times in media.
Generation of Monoclonal Antibodies
BALB/cByJ mice were immunized subcutaneously with human TIM-
1(IgV)-Ig or TIM-4(IgV)-Ig in CFA and boosted multiple times with the
protein in PBS or IFA. One day after final boost, lymph node cells
were fused with NS1 myeloma cells and cloned, and the hybridomas
were screened by cell-surface staining of human TIM-1- or TIM-
4-transfected 300.19 cells. 3D1 (mouse IgG1) and 1D12 (mouse
IgG1) for hTIM-1; 9F4 (mouse IgG1) and 4E11 (mouse IgG2b) for
hTIM-4 were chosen. Mouse TIM-1 mAb (3B3, rat IgG2a) has been de-
scribed (Umetsu et al., 2005). Mouse TIM-4 mAbs (21H12, rat IgG1 and
QT3, rat IgG2a) were made by immunization of a Lewis strain rat via
a similar protocol and will be described in detail elsewhere (unpub-
lished data). After purification with protein A-Sepharose, antibodies
were conjugated to phycoerythrin (PE) by Zymed Laboratories (South
San Francisco, CA).
Ig Fusion Proteins
TIM-Ig fusion proteins (FPs) consist of the complete TIM extracellular
domain (indicated as TIM-Ig) or the signal and IgV domain of the TIM
[indicated as TIM (IgV)-Ig] linked to the hinge-CH2-CH3 domains of
mouse IgG2a (with four point mutations blocking Fc receptor and
complement binding) in the pEF6 vector. The mouse TIM-1(IgV) fused
to a mouse IgG2a Fc tail (Umetsu et al., 2005) and human TIM-1 fused
to a human IgG1 Fc tail (Tami et al., 2007) have been described. Other
TIM-Ig were made in the same fashion as mTIM-1(IgV)-Ig (Umetsu
et al., 2005). Ig FPs were produced in stably transfected CHO cells
and purified from conditioned media by protein A-Sepharose chroma-
tography.
Cell Transfection
NIH 3T3 cells were transfected by electroporation with a pEF6 plasmid
containing hTIM-1 or with wild-type or mutant hTIM-4 cDNAs (W119A,
F120A, N121A, D122A). Cells were selected with blasticidin and sorted
by flow cytometry for hTIM-1 with 3D1-PE or for hTIM-4 with 9F4-PE or
4E11-PE.
Mutagenesis
Mutations of a hTIM-4 cDNA in pEF6 were made by oligonucleotide-
directed mutagenesis. For example, the D122A mutant was made by
PCR amplification of the vector + amino-terminal end and the middle
region of hTIM-4 with overlapping primer pairs: 50-GCTCGGATCCAC
TAGTCCAGTGTG-30 with 50- TTACAGCGTTGAACCAGCCAGGCAC
TTCTATG-30 and 50- CTGGCTGGTTCAACGCTGTAAAGATAAACGT
G-30 with 50- TGTGGCTTCCTCCGGAAGGGTGCTTGGGGTTA-30, re-
spectively. The two PCR fragments were incubated with Spe I- andImBspE I-digested Tim-4 plasmid, joined by In-Fusion assembly (Zhu
et al., 2007), and transformed into E. coli, and the sequence was con-
firmed.
Immunohistochemistry
Immunostaining for TIM-4 was performed on formalin-fixed paraffin-
embedded human tissue sections following microwave antigen
retrieval in 10 mM citrate buffer, pH 6.0, via a standard indirect avi-
din-biotin horseradish peroxidase (HRP) method and diaminobenzi-
dine color development, as previously described (Dorfman et al.,
2003). Immunostaining with goat anti-human TIM-4 polyclonal anti-
body (R&D Systems) was compared with that of goat IgG control
antibody diluted to identical protein concentration for all cases studied
in order to confirm staining specificity. The specificity of TIM-4 immu-
nostaining was also compared after absorption of the TIM-4 antibody
on TIM-4-transfected 300.19 cells or untransfected 300.19 cells.
Transmission Electron Microscopy
HTIM-4-transfected 3T3 cells were incubated with apoptotic U937 for
90 min, washed, and fixed in 0.1M cacodylate buffer (pH 7.4) contain-
ing 2.5% formaldehyde, 5% glutaraldehyde, and 0.06% picric acid.
Fixed cells were embedded in Epon-araldite and 2.4 volumes of dode-
cenyl succinic anhydride and propylene oxide and hardened at 60.
Thin sections (1 mm or less) were examined with a JEM-1200 EX
electron microscope.
Quantitative RT-PCR
Total RNA was extracted from cells or organs with Trizol (Invitrogen).
Human thymus, liver, kidney, lung, and testis RNAs were from multi-
ple-tissue cDNA panels (Clontech). Reverse transcription was done
with Taqman reverse-transcription reagents (Applied Biosystems)
with Oligo(dT) as the primer, following the manufacturer’s protocol.
The mouse and human TIM-4 and GAPDH primer-probe sets were
purchased from Applied Biosystems. Taqman Universal PCR Master
Mix and the 7500 Real-Time PCR System (Applied Biosystems) were
used for PCR. Comparative threshold cycles (CT) was used to deter-
mine gene expression. For each sample, the TIM-4 CT value was nor-
malized with the formula DCT = CTTIM-4  CTGAPDH. For relative
expression, the meanDCT was determined, and relative TIM-4 expres-
sion was calculated with the formula 2DCT.
Preparation of Primary Cells and Cell Separation
Cells from human spleen were obtained by physical disruption fol-
lowed by filtration through a 70 mm nylon cell strainer (BD Bioscience).
Mononuclear cells were separated by Ficoll-Hypaque (GE-Healthcare)
and washed with PBS with 2% FBS. CD14+ and CD14 cells were pu-
rified through positive selection by MACS Sort magnetic beads in
MACS LS Separation columns (Miltenyi Biotec). The percentages of
CD14+ cells were analyzed by flow cytometry with FITC-conjugated
human CD14 mAb (BD PharMingen) and were greater than 70% in
CD14+ cells and less than 0.9% in CD14 cells. Adherent splenic cells
were prepared by culture on tissue-culture plates for 2 hr at 37C, and
nonadherent cells were removed by washing with PBS.
Flow Cytometry
For determination of cell-surface mTIM-4 expression on freshly iso-
lated cells, cells were preincubated with Fc receptor mAb (2.4G2,
ATCC) for 15 min to block Fc receptors. Peritoneal cells were stained
with allophycocyanin-conjugated F4/80 mAb (BD PharMingen).
CD11c+ cells were purified by positive selection (using MACS CD11c
microbeads [Miltenyi Biotec]) from spleen and stained with PE-Cy5-
anti-CD8a (clone 53-6.7). B cells were stained with anti-CD19 (FITC)
(BD PharMingen). Cells were costained with PE-conjugated mTIM-4
mAb or isotype control, washed, and analyzed. For determination of
TIM-Ig binding, cells were stained with TIM-Ig or isotype control in
PBS + 2% FCS + 0.02% NaN3 for 30 min on ice, washed twice, and
then stained with PE- or allophycocyanin-conjugated goat F(ab’)2
anti-mouse IgG2a or PE-conjugated anti-human IgG (Southernmunity 27, 927–940, December 2007 ª2007 Elsevier Inc. 937
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mAbs blocked binding of TIM-Ig, the indicated TIM-Ig was preincu-
bated with TIM mAb or isotype control for 30 min and then used to stain
cells as described above. Flow cytometry was performed on a
Cytomics FC500 (Beckman-Coulter), and data were processed with
FlowJo software (Tree Star).
Preparation of Apoptotic Cells and Eryptotic RBCs
Jurkat cells were cultured for 3 hr in the presence of agonistic anti-
human CD95 mAb (7C11, IgM, 1:500 to 1:2000 dilution of ascites)
(Robertson et al., 1995). The U937 human monocyte cell line was incu-
bated with 50 mM etoposide (Sigma) for 5 hr. Thymocytes from C57BL/
6 mice were incubated with 10 mM dexamethasone (Sigma) in RPMI for
3 hr. Human RBCs from fresh human blood were separated from
plasma, platelets, and PBMCs by Ficoll-Hypaque centrifugation. After
centrifugation, neutrophils and the upper 10% of RBCs were removed
by pipetting. The remaining RBCs were washed twice and incubated in
RPMI containing 4 mM ionomycin (Sigma) and 1 mM CaCl2 for 3 hr as
described previously (Lang et al., 2005). Apoptosis and PS expression
on the outer leaflet of the plasma membrane were detected by staining
with AnnexinV-FITC and propidium iodide kit (BD PharMingen). After
treatment, U937 were washed three times and labeled with 2–5 mM
of CellTracker Orange (CMTMR, Molecular Probes, FL2 channel) and
thymocytes or RBCs with 1–2 mM PKH67 (Sigma, FL1 channel)
according to the manufacturer’s instructions.
Phospholipid-Liposome Preparation
Small unilamellar liposomes containing the indicated phospholipids(s)
(Avanti Polar Lipids) were made as described previously (Fadok et al.,
2000). A plus symbol (PS + PC) indicates a 50:50 molar mix of the
indicated lipids. The lipids were mixed in chloroform, dried, resus-
pended in PBS, mixed, and sonicated for 3 min.
Phagocytosis Assay
Resident peritoneal cells (1 3 106) were cultured in 24-well plates for
2 hr and washed with PBS three times. mTIM-4 mAb or isotype control
was added to the cells in media and preincubated for 5 min before the
addition of 13 106 PKH67-labeled apoptotic thymocytes. After 30 min
at 37C, cells were washed twice with cold PBS and then detached
from the plates by treatment with 0.05% trypsin and 0.02% EDTA
(Cellgro). Collected cells were stained with PE-conjugated CD11b
mAb (BD PharMingen) and analyzed by flow cytometry. CD11b+ cells
that were also PKH67+ were counted as phagocytic.
Phagocytosis by TIM-transfected 3T3 cells or the human renal clear-
cell carcinoma 769P cell line (ATCC) was measured by first culturing
53 104 cells in 24-well plates for 2 days. Cells were then coincubated
with labeled live or apoptotic U937 or fresh or eryptotic RBCs for 45 to
90 min at 37C. Plates were quickly washed three times with cold PBS
with 0.5 mM EDTA to remove nonadherent U937 or RBCs and then de-
tached by treatment with 0.05% trypsin and 0.02% EDTA (Cellgro) and
analyzed by flow cytometry. TIM 3T3 or 769P cells were gated by for-
ward and side scatter. For examination of whether liposomes contain-
ing PS blocked phagocytosis, cells were preincubated with phospho-
lipid liposomes for 10 min and then incubated with eryptotic RBCs.
Where indicated, cells were preincubated with TIM mAb or isotype
control for 30 min before the addition of eryptotic RBCs.
Phagocytosis was also evaluated by confocal and fluorescent
microscopy. TIM-transfected 3T3 cells or 769P cells (5 3 104) were
cultured for 2 days in 4-well Lab-Tek II Chamber Slides (Nalge
Nunc). Slides were washed one time with RPMI without serum, and
cells were labeled with 2–5 mM of CellTracker Green (CMFDA, Molec-
ular Probes) in RPMI according to the manufacturer’s instructions.
Cells were coincubated with CMTMR-labeled U937 for 45 to 90 min.
Slides were quickly washed three times with cold PBS with 0.5 mM
EDTA and fixed with 3% paraformaldehyde. Samples were analyzed
on a Nikon TE2000-U inverted Microscope with EZ-C1 software
(Nikon) or an Olympus CKX41.938 Immunity 27, 927–940, December 2007 ª2007 Elsevier IncpH-Sensitive Dye Labeling of Apoptotic Cells
Apoptotic U937 were washed three times with PBS, labeled with 2 mM
CypHer5E Mono NHS ester (GE Healthcare) in PBS for 20 min at room
temperature, washed, incubated with hTIM-4-transfected 3T3 cells for
100 min, and washed. Localization of apoptotic bodies from neutral
cell surface (colorless) into acidic intracellular endosomes (deep red)
was detected by excitation with a 635 nm laser, and emission fluores-
cence was collected with the Fluoview 1000 spectral scanner (Olym-
pus). Images were manipulated in Volocity (Improvision, Waltham,
MA) for presentation in movie format. Photoshop and NIH ImageJ
were used to composite images.
PIP-Strip Assay
PIP strips on which the indicated phospholipids had been spotted
were purchased from Echelon Bioscience. Dot-blot experiments
were carried out according to the manufacturer’s protocol. Strips
were incubated overnight in StartingBlock (TBS) Blocking Buffer
(Pierce) at 4C and then transferred to 2 mg/ml of TIM-Ig in blocking
buffer with 0.5 mM CaCl2 for 2 hr. The PIP strip was then washed three
times in TBST (140 mM NaCl, 10 mM Tris-HCl, 0.1% Tween20) with
0.5 mM CaCl2 before incubating with HRP-conjugated rat anti-mouse
IgG2a mAb (BD PharMingen). Antibody binding was detected with ECL
plus western-blotting detection reagents (Amersham Bioscience) and
visualized with Kodak X-Omat 2000A processor.
Solid-Phase ELISA
The solid-phase ELISA for TIM binding to phospholipids was carried
out as described (Hanayama et al., 2002). In brief, the indicated phos-
pholipids in methanol (5 mg/ml, 100 ml) were added to polystyrene
ELISA plates and air-dried. The plates were then blocked with 2%
BSA in PBS. TIM-Ig or PS mAb (clone 1H6, mIgG2a, Upstate) were
diluted in PBS, added to the wells, and incubated at room temperature
for 2 hr. The plates were washed with PBS with 0.05% Tween 20
before incubation with goat F(ab’)2 anti-mouse IgG2a biotin and Strep-
tavidin-HRP (Southern Biotech) for mTIM-1, mTIM-2, mTIM-4, and
hTIM-4-Ig or goat anti-human IgG-HRP (Jackson Immunoresearch)
for hTIM-1-Ig. The absorbance at 450 nm was measured with Spectra
Max190 (Molecular Devices).
Supplemental Data
Four figures and one movie are available at http://www.immunity.com/
cgi/content/full/27/6/927/DC1/.
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